Abstract
It is now widely recognized that the Western World has reached a high standard of living through the improvement of technologies and their application to environmental protection, safety, and health. The quality of life results in particular from improvement in health care comprising all measures of prevention, early detection, and treatment of diseases. To this end a large number of biomedical analyses are carried out, and their reliability must be guaranteed. For this purpose in most of the EC Member States a system of quality assurance (QA) for these analyses has been established. From this standpoint QA plays a key role in the improvement of analyses carried out in European clinical laboratories. The involvement of the Community Bureau of Reference (BCR) program in relation to QA is outlined. Emphasis is also placed on the role of BCR in fostering collaboration between organizers of QA schemes as well as on the concept of and means of securing traceability of results in this field.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
